159 related articles for article (PubMed ID: 34485152)
1. Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection.
Li P; Wu L; Li Z; Li J; Ye W; Shi Z; Xu Z; Zhu C; Ye H; Liu Z; Liang C
Front Oncol; 2021; 11():716849. PubMed ID: 34485152
[TBL] [Abstract][Full Text] [Related]
2. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
[TBL] [Abstract][Full Text] [Related]
3. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
[TBL] [Abstract][Full Text] [Related]
4. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
[TBL] [Abstract][Full Text] [Related]
5. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
6. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
7. Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection.
Li N; Wan X; Zhang H; Zhang Z; Guo Y; Hong D
BMC Cancer; 2022 Jun; 22(1):664. PubMed ID: 35715783
[TBL] [Abstract][Full Text] [Related]
8. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
9. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
10. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation.
Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L
Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862
[TBL] [Abstract][Full Text] [Related]
11. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
Yang Y; Zhou Y; Zhou C; Ma X
Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
[TBL] [Abstract][Full Text] [Related]
12. Radiomics analysis of [
Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
[TBL] [Abstract][Full Text] [Related]
13. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
14. MRI radiomics based on deep learning automated segmentation to predict early recurrence of hepatocellular carcinoma.
Wei H; Zheng T; Zhang X; Wu Y; Chen Y; Zheng C; Jiang D; Wu B; Guo H; Jiang H; Song B
Insights Imaging; 2024 May; 15(1):120. PubMed ID: 38763975
[TBL] [Abstract][Full Text] [Related]
15. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation.
Zhang L; Cai P; Hou J; Luo M; Li Y; Jiang X
Cancer Manag Res; 2021; 13():2785-2796. PubMed ID: 33790652
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma.
Xu T; Ren L; Liao M; Zhao B; Wei R; Zhou Z; He Y; Zhang H; Chen D; Chen H; Liao W
J Hepatocell Carcinoma; 2022; 9():189-201. PubMed ID: 35340666
[TBL] [Abstract][Full Text] [Related]
17. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma.
Ning P; Gao F; Hai J; Wu M; Chen J; Zhu S; Wang M; Shi D
Abdom Radiol (NY); 2020 Jan; 45(1):64-72. PubMed ID: 31486869
[TBL] [Abstract][Full Text] [Related]
18. A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study.
Dai Y; Cheng Y; Zhou Z; Li Z; Luo Y; Qiu H
PeerJ; 2023; 11():e16230. PubMed ID: 37849829
[TBL] [Abstract][Full Text] [Related]
19. CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection.
Wang F; Chen Q; Zhang Y; Chen Y; Zhu Y; Zhou W; Liang X; Yang Y; Hu H
J Hepatocell Carcinoma; 2022; 9():453-465. PubMed ID: 35646748
[TBL] [Abstract][Full Text] [Related]
20. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
